Infigratinib mesylate

DESCRIPTION

Infigratinib mesylate (BGJ398) is an orally bioavailable pan inhibitor of human FGFR with potential antiangiogenic and antineoplastic activities.

DETAILS

Cas: 1310746-12-3
Purity: 98%
Smiles: CS(O)(=O)=O.CCN1CCN(CC1)c1ccc(Nc2cc(ncn2)N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)cc1
Category: Compound
Molecular Weight: 656.58
Molecular Formula: C27H35Cl2N7O6S

Lead Time: 4 - 5 weeks